Sectoral Asset Management Inc Iovance Biotherapeutics, Inc. Transaction History

Sectoral Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $2.59 Million - $6.99 Million	-786,200 Reduced 79.82%	198,800 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $4.37 Million - $8.66 Million	985,000 New	985,000 $4.48 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $1.42 Million - $4.07 Million	-222,000 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$12.38 - $19.1 $2.75 Million - $4.24 Million	222,000 New	222,000 $3.7 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $577,200 - $755,039	-20,800 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $565,968 - $852,800	20,800 New	20,800 $571,000
Q4 2018 Feb 12, 2019	SELL	$7.51 - $11.93 $97,307 - $154,577	-12,957 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $145,766 - $229,338	12,957 New	12,957 $146,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.